Rabies is a rare, fatal viral infection, usually transmitted by the bite of an infected animal. Some 30,000 Americans are immunized annually, however, so public health considerations are common. The development of a new vaccine, grown in human diploid cell culture, is discussed. It appears to have high antigenicity with no serious morbidity. A case of a patient with fatal rabies who had fever, delirium, dysphagia, and cervical and pectoral subcutaneous emphysema is presented.
HattwickMAWWeisTTStechschulteCJ: Recovery from rabies. Ann Int Med76: 931–942, 1972.
2.
PorrasCBarbozaJJFuenzalidaE: Recovery from rabies in man. Ann Int Med85: 44–48, 1976.
3.
WilsonJMHettiarachchiJWijesuriyaLM: Presenting features and diagnosis of rabies. Lancet2: 1139–1140, 1975.
4.
KochFJSagartzJWDavidsonDE: Diagnosis of rabies by the cornea test. Am J Clin Pathol63: 509–515, 1975.
5.
GarnerWRJonesDOPrattE: Problems associated with rabies preexposure prophylaxis. JAMA235: 1131–1132, 1976.
6.
BahmanyarMFayazMNour-SalehiS: Successful protection of humans exposed to rabies infection. JAMA236: 2751–2754, 1976.
7.
CoxJHSchneiderLG: Prophylactic immunization of humans against rabies by intradermal innoculation of human diploid cell culture vaccine. J Clin Microbiol3: 96–101, 1976.
